Clinical Trial Update: Counterpulsation Reduces Infarct Size Pre-PCI for AMI [Phase 4]

View source ↗

Summary

A completed Phase 4 trial evaluated counterpulsation before percutaneous coronary intervention in Acute Myocardial Infarction and found reduced infarct size.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Intra-aortic balloon pump counterpulsation (Intra-aortic balloon pump)

Snippet

Sponsor: Datascope Corp. | Conditions: Acute Myocardial Infarction (AMI) | Phase 4 | Status: COMPLETED